Lilly: Seeking Solutions to a Global MDR-TB Crisis

Primary tabs

Lilly: Seeking Solutions to a Global MDR-TB Crisis

tweet me:
What’s new in the fight against #MDR-TB? Find out! http://ow.ly/DyRTU #globalhealth
Friday, October 31, 2014 - 11:00am

CAMPAIGN: Lilly Global Health Programs

CONTENT: Blog

Over a decade ago, we committed ourselves to the global fight against multi-drug resistant tuberculosis (MDR-TB). Today, a new report out from the Lilly MDR-TB Partnership shares insights from a core component of the partnership: the technology transfer program. The process began when independent researchers identified two Lilly-manufactured medicines as effective treatments for MDR-TB. 
 
Equipped with that knowledge, we endeavored to set-up a novel solution to combat the global rise of the disease. To create a reliable and sustainable supply of these two medicines, we transferred our trademarks, manufacturing technology, and knowledge to manufacturers in the most affected countries. The new report seeks to tell that story and share lessons learned.
 
Keywords: Health & Healthcare | Eli Lilly and Company | Lilly | Lilly MDR-TB Partnership | Technology Transfer | sustainability | tuberculosis (MDR-TB)

CAMPAIGN: Lilly Global Health Programs

CONTENT: Blog

parse.ly